Novel three-pronged strategy to enhance cancer cell killing in glioblastoma cell lines: histone deacetylase inhibitor, chemotherapy, and oncolytic adenovirus dl520.

Source:http://linkedlifedata.com/resource/pubmed/id/16409125

Download in:

View as

General Info

PMID
16409125